{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:16:23Z","timestamp":1792664183913,"version":"4.5.0"},"reference-count":39,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,4,16]],"date-time":"2012-04-16T00:00:00Z","timestamp":1334534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2012,9]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> Haemostatic effect of compounds for treating haemophilia can be evaluated in various bleeding models in haemophilic mice. However, the doses of factor VIII (FVIII) for normalizing bleeding used in some of these models are reported to be relatively high. The aim of this study was to establish a sensitive venous bleeding model in FVIII knock out (F8\u2010KO) mice, with the ability to detect effect on bleeding at low plasma FVIII concentrations. We studied the effect of two recombinant FVIII products, N8 and Advate<jats:sup>\u00ae<\/jats:sup>, after injury to the saphenous vein. We found that F8\u2010KO mice treated with increasing doses of either N8 or Advate<jats:sup>\u00ae<\/jats:sup> showed a dose\u2010dependent increase in the number of clot formations and a reduction in both average and maximum bleeding time, as well as in average blood loss. For both compounds, significant effect was found at doses as low as 5\u2003IU\u2003kg<jats:sup>\u22121<\/jats:sup> when compared with vehicle\u2010treated F8\u2010KO mice. Normalization of maximum bleeding time was found at doses equal to or above 10\u2003IU\u2003kg<jats:sup>\u22121<\/jats:sup>\u2003N8 or Advate<jats:sup>\u00ae<\/jats:sup>, corresponding to plasma concentrations of approximately 10% of the level in wild type mice. The present study adds a new model to the armamentarium of bleeding models used for evaluation of pro\u2010coagulant compounds for treatment of haemophilia. Interestingly, the vena saphena model proved to be sensitive towards FVIII in plasma levels that approach the levels preventing bleeding in haemophilia patients, and may, thus, in particular be valuable for testing of new long\u2010acting variants of e.g. FVIII that are intended for prophylaxis.<\/jats:p>","DOI":"10.1111\/j.1365-2516.2012.02780.x","type":"journal-article","created":{"date-parts":[[2012,4,16]],"date-time":"2012-04-16T10:09:50Z","timestamp":1334570990000},"page":"782-788","source":"Crossref","is-referenced-by-count":49,"title":["A sensitive venous bleeding model in haemophilia A mice: effects of two recombinant FVIII products (N8 and Advate<sup>\u00ae<\/sup>)"],"prefix":"10.1111","volume":"18","author":[{"given":"A. E.","family":"PASTOFT","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"LYKKESFELDT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"EZBAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"TRANHOLM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. C.","family":"WHINNA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"LAURITZEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,4,16]]},"reference":[{"key":"e_1_2_8_2_2","first-page":"560","article-title":"Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis","volume":"85","author":"White GC","year":"2000","journal-title":"Thromb Haemost"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03703.x"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(96)80062-X"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-009-0676-x"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.01036.x"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0595-119"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.9.3446.bloodjournal8893446"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614401"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1614439"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1258\/la.2010.009113"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1615666"},{"key":"e_1_2_8_13_2","first-page":"P\u2010M\u2010030","article-title":"Comparison of Human and Murine rFVIII in a Standardized FVIII Dependent Bleed Model in FVIII \u2010\/\u2010 Mice. Cui Z\u2010H, Canivel D, Lollar P, Parker ET, Landskroner KA, editors","volume":"5","author":"Jesmok J","year":"2007","journal-title":"J Thromb Haemost"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613377"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2009.02133.x"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01236.x"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2004.00899.x"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.02954.x"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-254755"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01260.x"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-136820"},{"key":"e_1_2_8_22_2","first-page":"PP\u2010MO\u2010379","article-title":"A novel murine hemostasis model: studies on recombinant factor VIIa and NN1731","volume":"7","author":"Whinna HC","year":"2009","journal-title":"J Thromb Haemost"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03287.x"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.03270.x"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2010.02333.x"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03532.x"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2011.02580.x"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2011.02495.x"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2009.02135.x"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2011.02608.x"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-212423"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.04084.x"},{"key":"e_1_2_8_33_2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-0038-1657230","article-title":"Bleeding time in rats: a comparison of different experimental conditions","volume":"48","author":"Dejana E","year":"1982","journal-title":"Thromb Haemost"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm782"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-04-152959"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(90)90106-M"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2004.07.009"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003086-199607000-00003"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2006.01268.x"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01870.x"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2012.02780.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2516.2012.02780.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T22:15:05Z","timestamp":1695507305000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2012.02780.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,16]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["10.1111\/j.1365-2516.2012.02780.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2012.02780.x","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,16]]}}}